PennRheum
@PennRheum
Followers
761
Following
117
Statuses
238
Penn Medicine's Division of Rheumatology National leader in diagnosis, treatment, and research in autoimmune diseases @PennMDForum
Philadelphia, PA
Joined October 2020
Vessel wall imaging in GCA is a promising modality for diagnosis. New pub from Dr. Rhee from @PennMedicine along with VCRC collabs outlines standardized protocol and scoring for these images.
0
0
0
RT @miner_lab: And now—with the help of amazing collaborators @PennMedicine —we can convert the toxic TREX1 protein (dominant, truncated TR…
0
11
0
RT @miner_lab: Our latest findings: Mislocalized TREX1 causes DNA damage in flies, mice, & humans with RVCL, a mimic of lupus and radiation…
0
16
0
Stress and trauma are associated with worse PRO's in SLE, and perceived stress with greater SLE activity. Attn to improving positive and reducing negative psychosocial factors may be beneficial for stress in these pts. Dr. Kim Dequattro @PennMedicine
0
0
1
RT @USSONAR_Rh: @danaddirenzo @PennRheum presents on the use of #Ultrasound in salivary glands #Sjogrens US has utility on longitudinal ass…
0
1
0
RT @USSONAR_Rh: @danaddirenzo @PennRheum presents on the use of #Ultrasound in salivary glands #Sjogrens US has utility on longitudinal as…
0
1
0
RT @JonathanDauMD: Dana DiRenzo, M.D. of @PennRheum at the @USSONAR_Rh MULTI TRACK ULTRASOUND COURSE in her element teaching Salivary Glan…
0
2
0
RT @USSONAR_Rh: @danaddirenzo @PennRheum presents on the use of #Ultrasound in salivary glands #Sjogrens US has utility on longitudinal as…
0
1
0
Fibromyalgia: a common comorbidity in PsA - up to 11% of patients fulfill criteria, and over 1 in 5 fulfill definition of widespread pain. Really complicates assessment of disease activity, esp when it comes to enthesitis! @AlexisOgdie
0
0
0
Case series of 8 pts with SSc receiving ICI for cancer dx - iRAE common, but in this series ICI well tolerated. @jhrheumatology and Penn Rheum collab! @seminarthrheum
@danaddirenzo @JonathanKotzin @cappelliMD
0
0
0
Featuring @AlexisOgdie @DrPeterMerkel @rheumecraig @DrChadJohr @s_apostolidis @danaddirenzo just to name those I have twitter names for! Full program:
0
1
2
RT @KDAO2011: Attention 1st year Rheum Fellows— UPenn Medicine puts on an Annual conference just for you! It’s free for in person attendan…
0
5
0
Benralizumab noninferior to mepolizumab for induction in patients with relapsing/refractory eGPA. Great to have a new med in the arsenal for this tough disease. From @DrPeterMerkel and MANDARA study group @PennMedicine @Penn @VasculitisFound
0
0
1
Clinically meaningful improvements in pain (40%) and physical function (30%) after 6 months in patients with PsA treated with guselkumab. Notable that ~90% of these pts were treatment refractory. From Penn's @AlexisOgdie and colleagues
0
0
3
RT @takeapaincheck: Our Joint Chat Rheum will be held on Zoom on February 25th at 6 PM EST / 3 PM PST. Join the opportunity to get involved…
0
3
0
RT @drlalonares: ☝🏼Happy to have collaborated in the GLOBAL-PAN study led by @dr_omerkaradag. The low prevalence of #PAN necessitates a glo…
0
13
0
Upa looked good in trials - what about real world? Josh Baker and colleagues using @corevitasdata: 46% MCID improvement in CDAI and 40% CDAI LDA, regardless of prior TNF exposure, line of tx, or use of csDMARDs.
0
0
0